{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:20:39Z","timestamp":1774974039343,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700579 and 81670612"],"award-info":[{"award-number":["81700579 and 81670612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Three-year Project of Action for Shanghai Public Health System","award":["GWIV-18"],"award-info":[{"award-number":["GWIV-18"]}]},{"name":"the National Key Research and Development Program of China","award":["2016YFC0901502"],"award-info":[{"award-number":["2016YFC0901502"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11255-018-1951-5","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T05:58:12Z","timestamp":1534226292000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The association between autosomal dominant polycystic kidney disease and cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Ke","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dechao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"issue":"2","key":"1951_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76(2):149\u2013168","journal-title":"Kidney Int"},{"issue":"2","key":"1951_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MNH.0b013e3283262ab0","volume":"18","author":"V Patel","year":"2009","unstructured":"Patel V, Chowdhury R, Igarashi P (2009) Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens 18(2):99\u2013106","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"14","key":"1951_CR3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359(14):1477\u20131485","journal-title":"N Engl J Med"},{"issue":"2","key":"1951_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MNH.0b013e32835011a7","volume":"21","author":"TI Steinman","year":"2012","unstructured":"Steinman TI (2012) Polycystic kidney disease: a 2011 update. Curr Opin Nephrol Hypertens 21(2):189\u2013194","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"1951_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1067\/mlc.2003.13","volume":"141","author":"M Sutters","year":"2003","unstructured":"Sutters M, Germino GG (2003) Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med 141(2):91\u2013101","journal-title":"J Lab Clin Med"},{"issue":"9569","key":"1951_CR6","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369(9569):1287\u20131301","journal-title":"Lancet"},{"issue":"1","key":"1951_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000474961","volume":"42","author":"Q Yao","year":"2017","unstructured":"Yao Q, Wu M, Zhou J, Zhou M, Chen D, Fu L et al (2017) Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease. Kidney Blood Press Res 42(1):156\u2013164","journal-title":"Kidney Blood Press Res"},{"issue":"9","key":"1951_CR8","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1681\/ASN.2014121192","volume":"26","author":"C Antignac","year":"2015","unstructured":"Antignac C, Calvet JP, Germino GG, Grantham JJ, Guay-Woodford LM, Harris PC et al (2015) The Future of Polycystic Kidney Disease Research\u2013As Seen By the 12 Kaplan Awardees. J Am Soc Nephrol 26(9):2081\u20132095","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1951_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1053\/snep.2001.20929","volume":"21","author":"JP Calvet","year":"2001","unstructured":"Calvet JP, Grantham JJ (2001) The genetics and physiology of polycystic kidney disease. Semin Nephrol 21(2):107\u2013123","journal-title":"Semin Nephrol"},{"issue":"4","key":"1951_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/PAS.0b013e318271eff9","volume":"37","author":"Y Ding","year":"2013","unstructured":"Ding Y, Chen L, Deng FM, Melamed J, Fan R, Bonsib S et al (2013) Localized cystic disease of the kidney: distinction from cystic neoplasms and hereditary polycystic diseases. Am J Surg Pathol 37(4):506\u2013513","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1951_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4103\/IJPM.IJPM_357_16","volume":"60","author":"N Sahoo","year":"2017","unstructured":"Sahoo N, Patra S, Senapati S, Mishra TS (2017) Multicentric papillary and chromophobe renal cell carcinomas in a patient with autosomal dominant polycystic kidney disease: Report of a rare case. Indian J Pathol Microbiol 60(3):405\u2013408","journal-title":"Indian J Pathol Microbiol"},{"issue":"5","key":"1951_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"key":"1951_CR13","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1100\/tsw.2007.274","volume":"7","author":"S Ibrahim","year":"2007","unstructured":"Ibrahim S (2007) Increased apoptosis and proliferative capacity are early events in cyst formation in autosomal-dominant, polycystic kidney disease. ScientificWorld Journal 7:1757\u20131767","journal-title":"ScientificWorld Journal"},{"issue":"4","key":"1951_CR14","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/JCI44145","volume":"121","author":"SA Wander","year":"2011","unstructured":"Wander SA, Hennessy BT, Slingerland JM (2011) Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest 121(4):1231\u20131241","journal-title":"J Clin Invest"},{"issue":"1","key":"1951_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","volume":"319","author":"YY Zaytseva","year":"2012","unstructured":"Zaytseva YY, Valentino JD, Gulhati P, Evers BM (2012) mTOR inhibitors in cancer therapy. Cancer Lett 319(1):1\u20137","journal-title":"Cancer Lett"},{"issue":"3","key":"1951_CR16","doi-asserted-by":"publisher","first-page":"e33626","DOI":"10.1371\/journal.pone.0033626","volume":"7","author":"G Chen","year":"2012","unstructured":"Chen G, Chen H, Wang C, Peng Y, Sun L, Liu H et al (2012) Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts. PLoS One 7(3):e33626","journal-title":"PLoS One"},{"issue":"5","key":"1951_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1681\/ASN.2011040340","volume":"23","author":"Z Novalic","year":"2012","unstructured":"Novalic Z, van der Wal AM, Leonhard WN, Koehl G, Breuning MH, Geissler EK et al (2012) Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease. J Am Soc Nephrol 23(5):842\u2013853","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1951_CR18","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","volume":"63","author":"T Yamaguchi","year":"2003","unstructured":"Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Pelling JC et al (2003) Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 63(6):1983\u20131994","journal-title":"Kidney Int"},{"issue":"6","key":"1951_CR19","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"Harris PC, Torres VE (2014) Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest 124(6):2315\u20132324","journal-title":"J Clin Invest"},{"issue":"1","key":"1951_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1681\/ASN.2013040398","volume":"25","author":"VE Torres","year":"2014","unstructured":"Torres VE, Harris PC (2014) Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J Am Soc Nephrol 25(1):18\u201332","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"1951_CR21","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s40265-015-0475-x","volume":"75","author":"HA Blair","year":"2015","unstructured":"Blair HA, Keating GM. Tolvaptan (2015) A review in autosomal dominant polycystic kidney disease. Drugs 75(15):1797\u20131806","journal-title":"Drugs"},{"key":"1951_CR22","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.2147\/OTT.S164982","volume":"11","author":"S Wang","year":"2018","unstructured":"Wang S, Zhang Z, Qian W, Ji D, Wang Q, Ji B et al (2018) Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP\/PKA pathway in colorectal cancer. Onco Targets Ther 11:3765\u20133774","journal-title":"Onco Targets Ther"},{"issue":"7","key":"1951_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.15698\/mic2018.07.640","volume":"5","author":"MD Baroni","year":"2018","unstructured":"Baroni MD, Colombo S, Martegani E (2018) Antagonism between salicylate and the cAMP signal controls yeast cell survival and growth recovery from quiescence. Microb Cell 5(7):344\u2013356","journal-title":"Microb Cell"},{"issue":"1","key":"1951_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10549-015-3445-9","volume":"152","author":"H Dong","year":"2015","unstructured":"Dong H, Claffey KP, Brocke S, Epstein PM (2015) Inhibition of breast cancer cell migration by activation of cAMP signaling. Breast Cancer Res Treat 152(1):17\u201328","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1951_CR25","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1159\/000320149","volume":"117","author":"KG Schwensen","year":"2011","unstructured":"Schwensen KG, Burgess JS, Graf NS, Alexander SI, Harris DC, Phillips JK et al (2011) Early cyst growth is associated with the increased nuclear expression of cyclin D1\/Rb protein in an autosomal-recessive polycystic kidney disease rat model. Nephron Exp Nephrol 117(4):e93\u2013e103","journal-title":"Nephron Exp Nephrol"},{"issue":"7","key":"1951_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ncb3363","volume":"18","author":"S Kim","year":"2016","unstructured":"Kim S, Nie H, Nesin V, Tran U, Outeda P, Bai CX et al (2016) The polycystin complex mediates Wnt\/Ca(2+) signalling. Nat Cell Biol 18(7):752\u2013764","journal-title":"Nat Cell Biol"},{"issue":"14","key":"1951_CR27","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","volume":"18","author":"H Happe","year":"2009","unstructured":"Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH et al (2009) Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet 18(14):2532\u20132542","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1951_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbadis.2006.04.006","volume":"1762","author":"SJ Wilson","year":"2006","unstructured":"Wilson SJ, Amsler K, Hyink DP, Li X, Lu W, Zhou J et al (2006) Inhibition of HER-2(neu\/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim Biophys Acta 1762(7):647\u2013655","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1951_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s004670000495","volume":"16","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Gattone VH II, Sweeney WE, Avner ED (2001) Renal dysfunction but not cystic change is ameliorated by neonatal epidermal growth factor in bpk mice. Pediatr Nephrol 16(1):45\u201350","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"1951_CR30","doi-asserted-by":"publisher","first-page":"F944","DOI":"10.1152\/ajprenal.00387.2010","volume":"299","author":"T Yamaguchi","year":"2010","unstructured":"Yamaguchi T, Reif GA, Calvet JP, Wallace DP (2010) Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells. Am J Physiol Renal Physiol 299(5):F944\u2013F951","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"1951_CR31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","volume":"57","author":"T Yamaguchi","year":"2000","unstructured":"Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S et al (2000) cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57(4):1460\u20131471","journal-title":"Kidney Int"},{"issue":"2\u20133","key":"1951_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0163-7258(01)00132-2","volume":"90","author":"M Leszczyniecka","year":"2001","unstructured":"Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB (2001) Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther 90(2\u20133):105\u2013156","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1951_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/03009734.2012.659294","volume":"117","author":"A Jogi","year":"2012","unstructured":"Jogi A, Vaapil M, Johansson M, Pahlman S (2012) Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors. Ups J Med Sci 117(2):217\u2013224","journal-title":"Ups J Med Sci"},{"issue":"2","key":"1951_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbrc.2012.07.070","volume":"425","author":"T Wachi","year":"2012","unstructured":"Wachi T, Yoshida N, Funae Y, Ueno M, Germino GG, Hirotsune S et al (2012) Progesterone induced mesenchymal differentiation and rescued cystic dilation of renal tubules of Pkd1(\u2013\/\u2013) mice. Biochem Biophys Res Commun 425(2):212\u2013218","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"1951_CR35","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1172\/JCI21753","volume":"114","author":"V Chauvet","year":"2004","unstructured":"Chauvet V, Tian X, Husson H, Grimm DH, Wang T, Hiesberger T et al (2004) Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J Clin Invest 114(10):1433\u20131443","journal-title":"J Clin Invest"},{"issue":"2","key":"1951_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1076","volume":"33","author":"SM Nauli","year":"2003","unstructured":"Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X et al (2003) Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33(2):129\u2013137","journal-title":"Nat Genet"},{"issue":"8","key":"1951_CR37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/bies.20069","volume":"26","author":"SM Nauli","year":"2004","unstructured":"Nauli SM, Zhou J (2004) Polycystins and mechanosensation in renal and nodal cilia. Bioessays 26(8):844\u2013856","journal-title":"Bioessays"},{"issue":"5","key":"1951_CR38","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","volume":"64","author":"VE Torres","year":"2003","unstructured":"Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P et al (2003) EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64(5):1573\u20131579","journal-title":"Kidney Int"},{"issue":"10","key":"1951_CR39","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.bbadis.2010.10.004","volume":"1812","author":"NN Zheleznova","year":"2011","unstructured":"Zheleznova NN, Wilson PD, Staruschenko A (2011) Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells. Biochim Biophys Acta 1812(10):1301\u20131313","journal-title":"Biochim Biophys Acta"},{"key":"1951_CR40","doi-asserted-by":"publisher","first-page":"40505","DOI":"10.1038\/srep40505","volume":"7","author":"S Li","year":"2017","unstructured":"Li S, Xu W, Xing Z, Qian J, Chen L, Gu R et al (2017) A Conditional Knockout Mouse Model Reveals a Critical Role of PKD1 in Osteoblast Differentiation and Bone Development. Sci Rep 7:40505","journal-title":"Sci Rep"},{"issue":"Pt 2","key":"1951_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"M Canel","year":"2013","unstructured":"Canel M, Serrels A, Frame MC, Brunton VG (2013) E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 126(Pt 2):393\u2013401","journal-title":"J Cell Sci"},{"issue":"6","key":"1951_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110(6):673\u2013687","journal-title":"Cell"},{"issue":"7","key":"1951_CR43","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc3080","volume":"11","author":"D Wirtz","year":"2011","unstructured":"Wirtz D, Konstantopoulos K, Searson PC (2011) The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11(7):512\u2013522","journal-title":"Nat Rev Cancer"},{"key":"1951_CR44","doi-asserted-by":"publisher","unstructured":"Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a005058","DOI":"10.1101\/cshperspect.a005058"},{"issue":"5","key":"1951_CR45","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.celrep.2013.10.050","volume":"5","author":"D Hoshino","year":"2013","unstructured":"Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N et al (2013) Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep 5(5):1159\u20131168","journal-title":"Cell Rep"},{"issue":"7","key":"1951_CR46","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.cell.2012.11.024","volume":"151","author":"V Luga","year":"2012","unstructured":"Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E et al (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151(7):1542\u20131556","journal-title":"Cell"},{"issue":"4","key":"1951_CR47","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.4049\/jimmunol.1002991","volume":"186","author":"T Chen","year":"2011","unstructured":"Chen T, Guo J, Yang M, Zhu X, Cao X (2011) Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol 186(4):2219\u20132228","journal-title":"J Immunol"},{"issue":"1","key":"1951_CR48","first-page":"11","volume":"1198","author":"W Birchmeier","year":"1994","unstructured":"Birchmeier W, Behrens J (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198(1):11\u201326","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"1951_CR49","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","volume":"13","author":"P Igarashi","year":"2002","unstructured":"Igarashi P, Somlo S (2002) Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 13(9):2384\u20132398","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1951_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","volume":"109","author":"AK Bhunia","year":"2002","unstructured":"Bhunia AK, Piontek K, Boletta A, Liu L, Qian F, Xu PN et al (2002) PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109(2):157\u2013168","journal-title":"Cell"},{"issue":"4","key":"1951_CR51","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jmb.2007.03.070","volume":"369","author":"A Markoff","year":"2007","unstructured":"Markoff A, Bogdanova N, Knop M, Ruffer C, Kenis H, Lux P et al (2007) Annexin A5 interacts with polycystin-1 and interferes with the polycystin-1 stimulated recruitment of E-cadherin into adherens junctions. J Mol Biol 369(4):954\u2013966","journal-title":"J Mol Biol"},{"issue":"1","key":"1951_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.149.1.111","volume":"149","author":"AJ Charron","year":"2000","unstructured":"Charron AJ, Nakamura S, Bacallao R, Wandinger-Ness A (2000) Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells. J Cell Biol 149(1):111\u2013124","journal-title":"J Cell Biol"},{"issue":"5","key":"1951_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ceb.2011.08.005","volume":"23","author":"C Margadant","year":"2011","unstructured":"Margadant C, Monsuur HN, Norman JC, Sonnenberg A (2011) Mechanisms of integrin activation and trafficking. Curr Opin Cell Biol 23(5):607\u2013614","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"1951_CR54","doi-asserted-by":"publisher","first-page":"C831","DOI":"10.1152\/ajpcell.00032.2009","volume":"298","author":"S Israeli","year":"2010","unstructured":"Israeli S, Amsler K, Zheleznova N, Wilson PD (2010) Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells. Am J Physiol Cell Physiol 298(4):C831\u2013C846","journal-title":"Am J Physiol Cell Physiol"},{"issue":"Pt 1","key":"1951_CR55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1242\/jcs.03314","volume":"120","author":"R Zaidel-Bar","year":"2007","unstructured":"Zaidel-Bar R, Milo R, Kam Z, Geiger B (2007) A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. J Cell Sci 120(Pt 1):137\u2013148","journal-title":"J Cell Sci"},{"issue":"3","key":"1951_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cm.20005","volume":"58","author":"B Zimerman","year":"2004","unstructured":"Zimerman B, Volberg T, Geiger B (2004) Early molecular events in the assembly of the focal adhesion-stress fiber complex during fibroblast spreading. Cell Motil Cytoskeleton 58(3):143\u2013159","journal-title":"Cell Motil Cytoskeleton"},{"issue":"3","key":"1951_CR57","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1128\/MCB.22.3.901-915.2002","volume":"22","author":"M Hagel","year":"2002","unstructured":"Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE et al (2002) The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 22(3):901\u2013915","journal-title":"Mol Cell Biol"},{"issue":"21","key":"1951_CR58","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1128\/MCB.25.21.9700-9712.2005","volume":"25","author":"DA Hsia","year":"2005","unstructured":"Hsia DA, Lim ST, Bernard-Trifilo JA, Mitra SK, Tanaka S, den Hertog J et al (2005) Integrin alpha4beta1 promotes focal adhesion kinase-independent cell motility via alpha4 cytoplasmic domain-specific activation of c-Src. Mol Cell Biol 25(21):9700\u20139712","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1951_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ydbio.2005.06.034","volume":"286","author":"K Polgar","year":"2005","unstructured":"Polgar K, Burrow CR, Hyink DP, Fernandez H, Thornton K, Li X et al (2005) Disruption of polycystin-1 function interferes with branching morphogenesis of the ureteric bud in developing mouse kidneys. Dev Biol 286(1):16\u201330","journal-title":"Dev Biol"},{"issue":"2","key":"1951_CR60","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMra022161","volume":"350","author":"PD Wilson","year":"2004","unstructured":"Wilson PD (2004) Polycystic kidney disease. N Engl J Med 350(2):151\u2013164","journal-title":"N Engl J Med"},{"issue":"6","key":"1951_CR61","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/ncb2491","volume":"14","author":"H Liu","year":"2012","unstructured":"Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ et al (2012) MYC suppresses cancer metastasis by direct transcriptional silencing of alphav and beta3 integrin subunits. Nat Cell Biol 14(6):567\u2013574","journal-title":"Nat Cell Biol"},{"issue":"10","key":"1951_CR62","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1091\/mbc.e07-02-0142","volume":"18","author":"M Boca","year":"2007","unstructured":"Boca M, D\u2019Amato L, Distefano G, Polishchuk RS, Germino GG, Boletta A (2007) Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell cell mechanical adhesion. Mol Biol Cell 18(10):4050\u20134061","journal-title":"Mol Biol Cell"},{"issue":"2","key":"1951_CR63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1152\/physiolgenomics.00090.2014","volume":"47","author":"JX Xu","year":"2015","unstructured":"Xu JX, Lu TS, Li S, Wu Y, Ding L, Denker BM et al (2015) Polycystin-1 and Galpha12 regulate the cleavage of E-cadherin in kidney epithelial cells. Physiol Genomics 47(2):24\u201332","journal-title":"Physiol Genomics"},{"issue":"10","key":"1951_CR64","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1093\/hmg\/ddt672","volume":"23","author":"G Yao","year":"2014","unstructured":"Yao G, Su X, Nguyen V, Roberts K, Li X, Takakura A et al (2014) Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex. Hum Mol Genet 23(10):2769\u20132779","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1951_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00041552-199801000-00001","volume":"7","author":"MR Hammerman","year":"1998","unstructured":"Hammerman MR (1998) Renal programmed cell death and the treatment of renal disease. Curr Opin Nephrol Hypertens 7(1):1\u20133","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"1951_CR66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.V5112","volume":"5","author":"J Savill","year":"1994","unstructured":"Savill J (1994) Apoptosis and the kidney. J Am Soc Nephrol 5(1):12\u201321","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1951_CR67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00041552-199801000-00002","volume":"7","author":"CM Sorenson","year":"1998","unstructured":"Sorenson CM (1998) Life, death and kidneys: regulation of renal programmed cell death. Curr Opin Nephrol Hypertens 7(1):5\u201312","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"1951_CR68","doi-asserted-by":"publisher","first-page":"224","DOI":"10.31768\/2312-8852.2016.38(4):224-237","volume":"38","author":"AA Philchenkov","year":"2016","unstructured":"Philchenkov AA, Balcer-Kubiczek EK (2016) Molecular markers of apoptosis in cancer patients exposed to ionizing radiation: the post-Chornobyl view. Exp Oncol 38(4):224\u2013237","journal-title":"Exp Oncol"},{"issue":"4","key":"1951_CR69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","volume":"16","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ (2017) From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov 16(4):273\u2013284","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl","key":"1951_CR70","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT et al (2015) Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol 35(Suppl):S78\u2013S103","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1951_CR71","first-page":"1153","volume":"13","author":"J Lanoix","year":"1996","unstructured":"Lanoix J, D\u2019Agati V, Szabolcs M, Trudel M (1996) Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 13(6):1153\u20131160","journal-title":"Oncogene"},{"issue":"1","key":"1951_CR72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/NEJM199507063330104","volume":"333","author":"D Woo","year":"1995","unstructured":"Woo D (1995) Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333(1):18\u201325","journal-title":"N Engl J Med"},{"issue":"2","key":"1951_CR73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00019606-199804000-00001","volume":"7","author":"XJ Zhou","year":"1998","unstructured":"Zhou XJ, Kukes G (1998) Pathogenesis of autosomal dominant polycystic kidney disease: role of apoptosis. Diagn Mol Pathol 7(2):65\u201368","journal-title":"Diagn Mol Pathol"},{"issue":"12","key":"1951_CR74","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1681\/ASN.2013020176","volume":"24","author":"LX Fan","year":"2013","unstructured":"Fan LX, Zhou X, Sweeney WE Jr, Wallace DP, Avner ED, Grantham JJ et al (2013) Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts. J Am Soc Nephrol 24(12):2010\u20132022","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"1951_CR75","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1093\/hmg\/ddx349","volume":"26","author":"L Duplomb","year":"2017","unstructured":"Duplomb L, Droin N, Bouchot O, Thauvin-Robinet C, Bruel AL, Thevenon J et al (2017) A constitutive BCL2 down-regulation aggravates the phenotype of PKD1-mutant-induced polycystic kidney disease. Hum Mol Genet 26(23):4680\u20134688","journal-title":"Hum Mol Genet"},{"issue":"10","key":"1951_CR76","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.bbadis.2011.05.008","volume":"1812","author":"PD Wilson","year":"2011","unstructured":"Wilson PD (2011) Apico-basal polarity in polycystic kidney disease epithelia. Biochim Biophys Acta 1812(10):1239\u20131248","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1951_CR77","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.devcel.2007.10.007","volume":"13","author":"B Goldstein","year":"2007","unstructured":"Goldstein B, Macara IG (2007) The PAR proteins: fundamental players in animal cell polarization. Dev Cell 13(5):609\u2013622","journal-title":"Dev Cell"},{"issue":"11","key":"1951_CR78","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1158\/0008-5472.CAN-07-6814","volume":"68","author":"CM Karp","year":"2008","unstructured":"Karp CM, Tan TT, Mathew R, Nelson D, Mukherjee C, Degenhardt K et al (2008) Role of the polarity determinant crumbs in suppressing mammalian epithelial tumor progression. Cancer Res 68(11):4105\u20134115","journal-title":"Cancer Res"},{"issue":"11","key":"1951_CR79","doi-asserted-by":"publisher","first-page":"10157","DOI":"10.1074\/jbc.M309843200","volume":"279","author":"P Laprise","year":"2004","unstructured":"Laprise P, Viel A, Rivard N (2004) Human homolog of disc-large is required for adherens junction assembly and differentiation of human intestinal epithelial cells. J Biol Chem 279(11):10157\u201310166","journal-title":"J Biol Chem"},{"issue":"7","key":"1951_CR80","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1681\/ASN.2016040474","volume":"28","author":"T Weide","year":"2017","unstructured":"Weide T, Vollenbroker B, Schulze U, Djuric I, Edeling M, Bonse J et al (2017) Pals1 Haploinsufficiency Results in Proteinuria and Cyst Formation. J Am Soc Nephrol 28(7):2093\u20132107","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1951_CR81","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.devcel.2007.07.017","volume":"13","author":"T Nechiporuk","year":"2007","unstructured":"Nechiporuk T, Fernandez TE, Vasioukhin V (2007) Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-\/- mice. Dev Cell 13(3):338\u2013350","journal-title":"Dev Cell"},{"key":"1951_CR82","doi-asserted-by":"crossref","unstructured":"Xu D, Lv J, He L, Fu L, Hu R, Cao Y et al. Scribble influences cyst formation in autosomal-dominant polycystic kidney disease by regulating Hippo signaling pathway. FASEB J. 2018:fj201701376RR","DOI":"10.1096\/fj.201701376RR"},{"key":"1951_CR83","unstructured":"Walters WBW. Surgical aspects of polycystic kidney. Surg Obstet Gynecol. 1934:647\u201350"},{"issue":"9","key":"1951_CR84","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V491661","volume":"4","author":"DS Keith","year":"1994","unstructured":"Keith DS, Torres VE, King BF, Zincki H, Farrow GM (1994) Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 4(9):1661\u20131669","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1951_CR85","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","volume":"74","author":"P Hajj","year":"2009","unstructured":"Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B et al (2009) Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74(3):631\u2013634","journal-title":"Urology"},{"issue":"6","key":"1951_CR86","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1046\/j.1523-1755.2002.00374.x","volume":"61","author":"MD Denton","year":"2002","unstructured":"Denton MD, Magee CC, Ovuworie C, Mauiyyedi S, Pascual M, Colvin RB et al (2002) Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 61(6):2201\u20132209","journal-title":"Kidney Int"},{"issue":"10","key":"1951_CR87","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1681\/ASN.2013101122","volume":"25","author":"JB Wetmore","year":"2014","unstructured":"Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL et al (2014) Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol 25(10):2335\u20132341","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"1951_CR88","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S1470-2045(16)30250-9","volume":"17","author":"T-M Yu","year":"2016","unstructured":"Yu T-M, Chuang Y-W, Yu M-C, Chen C-H, Yang C-K, Huang S-T et al (2016) Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study. The Lancet Oncology 17(10):1419\u20131425","journal-title":"The Lancet Oncology"},{"issue":"1","key":"1951_CR89","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajpath.2013.09.007","volume":"184","author":"D Nardo De","year":"2014","unstructured":"De Nardo D, De Nardo CM, Latz E (2014) New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. Am J Pathol 184(1):42\u201354","journal-title":"Am J Pathol"},{"issue":"3","key":"1951_CR90","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/01.mnh.0000444814.49755.90","volume":"23","author":"A Chang","year":"2014","unstructured":"Chang A, Ko K, Clark MR (2014) The emerging role of the inflammasome in kidney diseases. Curr Opin Nephrol Hypertens 23(3):204\u2013210","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"1951_CR91","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","volume":"108","author":"V Takiar","year":"2011","unstructured":"Takiar V, Nishio S, Seo-Mayer P, King JD Jr, Li H, Zhang L et al (2011) Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci U S A 108(6):2462\u20132467","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1951_CR92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova I, Korbonits M (2014) Metformin\u2013mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol 10(3):143\u2013156","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"1951_CR93","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S1470-2045(16)30250-9","volume":"17","author":"TM Yu","year":"2016","unstructured":"Yu TM, Chuang YW, Yu MC, Chen CH, Yang CK, Huang ST et al (2016) Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study. Lancet Oncol 17(10):1419\u20131425","journal-title":"Lancet Oncol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1951-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1951-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1951-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T05:21:17Z","timestamp":1661750477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1951-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1951-5","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"15 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}